Evidence map›Paper›PMID 26108665›Full record

ArticleAmerican journal of physiology. Cell physiology2015

BH3 domain-independent apolipoprotein L1 toxicity rescued by BCL2 prosurvival proteins.

J F Heneghan, D H Vandorpe, B E Shmukler, J A Giovinazzo, J A Giovinnazo, J Raper, D J Friedman, M R Pollak, S L Alper

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Apolipoprotein L1 (APOL1) cation current in HEK-293 cells and in human podocytes.Pflugers Archiv : European journal of physiology · 2023
    Article
  8. Review
  9. Article
  10. Frontiers in genetics · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. APOL1 and kidney cell function.American journal of physiology. Renal physiology · 2019
    Review
  16. Review
  17. ApoL1 Overexpression Drives Variant-Independent Cytotoxicity.Journal of the American Society of Nephrology : JASN · 2018
    Article
  18. Review
  19. The Cell Biology of APOL1.Seminars in nephrology · 2017
    Review
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
    Corrigendum.2015 · Giovinnazo, J A [corrected to Giovinazzo, J A]
5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

J F HeneghanRenal Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Vascular Biology Research Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts; and.
D H VandorpeRenal Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Vascular Biology Research Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts; and.
B E ShmuklerRenal Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Vascular Biology Research Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts; and.
J A Giovinazzo
J A GiovinnazoThe Graduate Center and Department of Biological Sciences, Hunter College of the City University of New York, New York, New York.
J RaperThe Graduate Center and Department of Biological Sciences, Hunter College of the City University of New York, New York, New York.
D J FriedmanRenal Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Vascular Biology Research Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts; and.
M R PollakRenal Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts; and.
S L AlperRenal Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Vascular Biology Research Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts; and salper@bidmc.harvard.edu.
Beth Israel Deaconess Medical Center · USHarvard University · USCity University of New York · US

Funding

Basic and Translational Research Center for Reducing Health DisparitiesG12MD007599 · NIMHD · HUNTER COLLEGE · PI ANGULO, JESUS A · 2012 to 2017
$14.6M
APOL1 variants: Understanding the basis of disparities in rates of kidney diseaseR01MD007092 · NIMHD · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FRIEDMAN, DAVID J, POLLAK, MARTIN R. · 2012 to 2021
$4.3M
Molecular Mechanism of APOL1 Associated Kidney DiseaseR01MD007898 · NIMHD · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ALPER, SETH LEO, POLLAK, MARTIN R. · 2013 to 2017
$2.2M
NIMHD NIH HHS MD-007092NIMHD NIH HHS MD-007599NIMHD NIH HHS MD-007898NIMHD NIH HHS R01 MD007092NIMHD NIH HHS R01 MD007898
6 · The paper itself

Abstract

The potent trypanolytic properties of human apolipoprotein L1 (APOL1) can be neutralized by the trypanosome variant surface antigen gene product known as serum resistance-associated protein. However, two common APOL1 haplotypes present uniquely in individuals of West African ancestry each encode APOL1 variants resistant to serum resistance-associated protein, and each confers substantial resistance to human African sleeping sickness. In contrast to the dominantly inherited anti-trypanosomal activity of APOL1, recessive inheritance of these two trypanoprotective APOL1 alleles predisposes to kidney disease. Proposed mechanisms of APOL1 toxicity have included BH3 domain-dependent autophagy and/or ion channel activity. We probed these potential mechanisms by expressing APOL1 in Xenopus laevis oocytes. APOL1 expression in oocytes increased ion permeability and caused profound morphological deterioration (toxicity). Coexpression of BCL2 family members rescued APOL1-associated oocyte toxicity in the order MCL1 ∼ BCLW > BCLXL ∼ BCL2A1 ≫ BCL2. Deletion of nine nominal core BH3 domain residues abolished APOL1-associated toxicity, but missense substitution of the same residues abolished neither oocyte toxicity nor its rescue by coexpressed MCL1. The APOL1 BH3 domain was similarly dispensable for the ability of APOL1 to rescue intact mice from lethal trypanosome challenge. Replacement of most extracellular Na(+) by K(+) also reduced APOL1-associated oocyte toxicity, allowing demonstration of APOL1-associated increases in Ca(2+) and Cl(-) fluxes and oocyte ion currents, which were similarly reduced by MCL1 coexpression. Thus APOL1 toxicity in Xenopus oocytes is BH3-independent, but can nonetheless be rescued by some BCL2 family proteins.

Indexed as

Amino Acid SequenceAnimalsApolipoprotein L1ApolipoproteinsFemaleHumansLipoproteins, HDLMiceMolecular Sequence DataProtein Structure, TertiaryProto-Oncogene Proteins c-bcl-2Xenopus laevisAPOL1 protein, humanApolipoprotein L1ApolipoproteinsBCL2 protein, humanLipoproteins, HDLProto-Oncogene Proteins c-bcl-2apolipoprotein L1hydrodynamic gene deliverytrypanosometwo-electrode voltage clampXenopus oocyte

Identifiers

PMID26108665
PMCPMC4556898
OpenAlexW2247786458

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.